Giger O, Mortensen J E, Clark R B, Evangelista A
Department of Pathology, Episcopal Hospital, Philadelphia, PA 19125-1098, USA.
Diagn Microbiol Infect Dis. 1996 Mar;24(3):145-53. doi: 10.1016/0732-8893(96)00026-0.
The detection of antimicrobial agent resistance among ninety-eight Haemophilus influenzae isolates was assessed by six different antibiotic test methods: agar dilution on Mueller-Hinton agar supplemented with 5% lysed horse blood (MH-LHB), E-test using both Haemophilus test medium (HTM) agar and chocolate Mueller-Hinton (CMH) agar plates, Vitek Haemophilus susceptibility cards, and three overnight microdilution systems that included two commercial systems, Micro-Media and MicroScan, and the reference broth microdilution method using HTM broth. Agents tested in the study included ampicillin, amoxicillin/clavulanic acid (A/C), cefaclor, cefuroxime, cefotaxime, ceftriaxone, chloramphenicol, and trimethoprim/sulfamethoxazole. Both the reference HTM microbroth dilution method and agar dilution correctly classified all nine of the beta-lactamase negative ampicillin resistant (BLNAR) isolates. Each of the other test methods failed to detect one of the BLNAR strains, either because of growth failure (Micro-Media and MicroScan) or miscategorization of an isolate as susceptible (E-Test HTM, E-Test CMH, and Vitek). None of the test methods detected all six isolates identified as A/C resistant by HTM microbroth dilution. Of the remaining antimicrobials tested, ampicillin and cefuroxime yielded data that could be compared by all test methods. The very major, major, and minor errors for these two antimicrobials in comparison to the reference HTM microdilution method were as follows: Micro-Media (1.7%, 0%, and 4.8%); MicroScan (11.9%, 0%, and 8.1%); E-Test HTM (1.6%, 0%, and 2.0%); E-Test CMH (1.6%, 1.6%, and 4.6%); Vitek (8.1%, 0%, and 3.1%); and agar dilution on MH-LHB (0%, 0%, and 4.6%). Micro-Media and MicroScan panels failed to support the growth of 4.1% and 5.1% of the isolates, respectively.
通过六种不同的抗生素测试方法,评估了98株流感嗜血杆菌分离株对抗菌剂的耐药性:在补充有5%裂解马血的穆勒-欣顿琼脂(MH-LHB)上进行琼脂稀释法、使用嗜血杆菌测试培养基(HTM)琼脂平板和巧克力穆勒-欣顿(CMH)琼脂平板的E-test法、Vitek嗜血杆菌药敏卡,以及三种过夜微量稀释系统,其中包括两种商业系统Micro-Media和MicroScan,以及使用HTM肉汤的参考肉汤微量稀释法。该研究中测试的抗菌剂包括氨苄西林、阿莫西林/克拉维酸(A/C)、头孢克洛、头孢呋辛、头孢噻肟、头孢曲松、氯霉素和甲氧苄啶/磺胺甲恶唑。参考HTM微量肉汤稀释法和琼脂稀释法均正确分类了所有9株β-内酰胺酶阴性氨苄西林耐药(BLNAR)分离株。其他每种测试方法都未能检测到其中一株BLNAR菌株,原因要么是生长失败(Micro-Media和MicroScan),要么是将一株分离株误分类为敏感(E-Test HTM、E-Test CMH和Vitek)。没有一种测试方法能检测到通过HTM微量肉汤稀释法鉴定为A/C耐药的所有6株分离株。在测试的其余抗菌剂中,氨苄西林和头孢呋辛产生的数据可通过所有测试方法进行比较。与参考HTM微量稀释法相比,这两种抗菌剂的极重大、重大和微小误差如下:Micro-Media(1.7%、0%和4.8%);MicroScan(11.9%、0%和8.1%);E-Test HTM(1.6%、0%和2.0%);E-Test CMH(1.6%、1.6%和4.6%);Vitek(8.1%、0%和3.1%);以及在MH-LHB上进行琼脂稀释法(0%、0%和4.6%)。Micro-Media和MicroScan平板分别未能支持4.1%和5.1%的分离株生长。